Skip to content

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02831556
Enrollment
174
Registered
2016-07-13
Start date
2016-07-31
Completion date
2022-08-31
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Injuries, Aortic Aneurysm, Appendicitis, Bladder Abnominalies, Digestive System Diseases, Diverticulitis, Evidence of Cholecystectomy, Gallstones, Gastrointestinal Diseases, Intestinal Diseases, Intraabdominal Infections, Intrauterine Pregnancy, Kidney Stones, Ovarian Cysts, Pancreatitis, Polyps, Pregnancy, Pregnancy, Ectopic, Testicular Abnominalies, Tumors, Uterine Abnominalies, Uterine Fibroids, Vascular Disease

Keywords

Ultrasound, Abdomen, Pelvis, 3D

Brief summary

Summary 1. Purpose and Objective: The purpose of this study is to test the feasibility of rapid acquisition of point of care 3D ultrasound in obtaining abdominal and/or pelvic images. The study will use a newly developed acquisition method and post-processing technique to create three dimensional image models of the abdomen and/or pelvis. 2. Study activities and population group. The study population will be a convenience sample of patients of any age presenting to the Emergency Department with complaints necessitating a clinical abdominal and/or pelvic imaging. The study intervention includes acquisition of research ultrasound images, which will not be used for clinical care, and comparison of these images with clinically obtained images. Other clinical data such as surgical and pathology reports will also be reviewed. 3.Data analysis and risk/safety issues. This is a pilot study intended to determine feasibility and to refine image reconstruction algorithms. Research images will be compared to clinical images. Comparison of research images with final diagnosis will also occur. The research intervention, an ultrasound exam, has no known safety risks. The only risk to subjects is loss of confidentiality. This study is observational, not interventional, because the experimental ultrasound will be performed in all subjects and will not be used in the clinical care of patients (consequently, will not have the opportunity to affect clinical outcomes). Experimental images will be reviewed after completion of clinical care and will not be provided to the clinicians caring for the subjects. The investigators are not measuring the effect of the ultrasound examination on the subjects' outcomes.

Interventions

None listed

Sponsors

Wallace H. Coulter Foundation
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Potential subjects must present to the emergency department for evaluation of complaints suspected to be related to an abdominal or pelvic pathology. The clinical diagnostic plan before subject enrollment may include abdominal or pelvic ultrasound, CT scan and/or MRI. OR * Non-patient volunteer

Exclusion criteria

* Non-English speaking

Design outcomes

Primary

MeasureTime frame
Experimental ultrasound diagnosis agreement with final reference standard diagnosisComparison of experimental ultrasound diagnosis with final reference diagnosis will occur at approximately 4 weeks (average) after date of experimental ultrasound exam, to allow clinical follow-up to occur.

Secondary

MeasureTime frame
Duration of experimental ultrasound examThe duration of the experimental ultrasound exam in seconds will be digitally recorded at the time of its performance. We anticipate the ultrasound duration to be less than 600 seconds
Experimental ultrasound image quality.4 weeks (average). Images will be reviewed after the completion of each subject's acute care. Image review will usually occur within 4 weeks.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026